Serotonin syndrome-A focused review.
Mikkelsen N, Damkier P, Pedersen SA.
Basic Clin Pharmacol Toxicol. 2023 Aug;133(2):124-129. doi: 10.1111/bcpt.13912. Epub 2023 Jun 20.
Serotonin syndrome.
Maitland S, Baker M.
Drug Ther Bull. 2022 Jun;60(6):88-91. doi: 10.1136/dtb.2021.000032. Epub 2022 May 12.
The serotonin syndrome.
Boyer EW, Shannon M.
N Engl J Med. 2005 Mar 17;352(11):1112-20. doi: 10.1056/NEJMra041867.
Neuroleptic malignant syndrome and serotonin syndrome.
Tormoehlen LM, Rusyniak DE.
Handb Clin Neurol. 2018;157:663-675. doi: 10.1016/B978-0-444-64074-1.00039-2.
Serotonin syndrome: Preventing, recognizing, and treating it.
Wang RZ, Vashistha V, Kaur S, Houchens NW.
Cleve Clin J Med. 2016 Nov;83(11):810-817. doi: 10.3949/ccjm.83a.15129.
Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review.
Beakley BD, Kaye AM, Kaye AD.
Pain Physician. 2015 Jul-Aug;18(4):395-400.
Drug-Induced Serotonin Syndrome.
Bartlett D.
Crit Care Nurse. 2017 Feb;37(1):49-54. doi: 10.4037/ccn2017169.
Serotonin syndrome: a clinical review of current controversies.
Werneke U, Truedson-Martiniussen P, Wikström H, Ott M.
J Integr Neurosci. 2020 Dec 30;19(4):719-727. doi: 10.31083/j.jin.2020.04.314.
Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Perry PJ, Wilborn CA.
Ann Clin Psychiatry. 2012 May;24(2):155-62.
Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants.
Bai AD, McKenna S, Wise H, Loeb M, Gill SS.
JAMA Netw Open. 2022 Dec 1;5(12):e2247426. doi: 10.1001/jamanetworkopen.2022.47426.
